Study of non-cancer blood disorders in people with bleeding or clotting
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study follows people with inherited or acquired non-cancer blood disorders to better understand symptoms, causes, and how different treatments work over time. You may be placed into a disorder-specific group, depending on your diagnosis and testing results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a non-cancer blood disorder (bleeding or clotting problem).
- If your diagnosis is unclear, you have an abnormal bleeding-score on the ISTH Bleeding Assessment Tool.
- If you have a connective tissue disorder (like EDS-type problems), you also must have a bleeding tendency on that bleeding-score.
- You must qualify for an open, disease-specific study group (arm).
- You (or your guardian) must be able and willing to give consent and complete study tasks.
- You must be able to join this study through the ATHN Transcends dataset (already enrolled there or enrolling now).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This study is a registry that collects information about people with bleeding disorders like hemophilia A or B and von Willebrand disease. The goal is to better understand these conditions and improve care across participating treatment centers.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
This trial uses early genetic testing to find the cause of unexplained bleeding in people who may have an inherited bleeding disorder. The goal is to see if genetic testing can help diagnose these conditions sooner.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
Hear when a new Bleeding Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.